Northern Capital Management (Washington)’s AbbVie ABBV Stock Holding History

Northern Capital Management (Washington)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$421K	Hold	1,673	–	–	0.18%	33
2026 Q1	$364K	Hold	1,673	–	–	0.18%	33
2025 Q4	$382K	Buy	1,673 +301	+22%	+$68.6K	0.2%	30
2025 Q3	$318K	Hold	1,372	–	–	0.17%	34
2025 Q2	$255K	Hold	1,372	–	–	0.15%	34
2025 Q1	$287K	Hold	1,372	–	–	0.19%	33
2024 Q4	$244K	Sell	1,372 -114	-8%	-$21K	0.15%	34
2024 Q3	$294K	Sell	1,486 -43	-3%	-$8.03K	0.19%	30
2024 Q2	$262K	Sell	1,529 -182	-11%	-$30.1K	0.18%	30
2024 Q1	$312K	Buy	1,711 +107	+7%	+$18.4K	0.22%	27
2023 Q4	$249K	Buy	1,604 +3	+0.2%	+$437	0.22%	25
2023 Q3	$239K	Sell	1,601 -17	-1%	-$2.5K	0.22%	32
2023 Q2	$218K	Buy	1,618 +3	+0.2%	+$440	0.17%	39
2023 Q1	$257K	Buy	1,615 +3	+0.2%	+$459	0.22%	34
2022 Q4	$261K	Sell	1,612 -47	-3%	-$7.21K	0.25%	35
2022 Q3	$223K	Buy	1,659 +3	+0.2%	+$430	0.23%	32
2022 Q2	$254K	Sell	1,656 -216	-12%	-$33K	0.25%	30
2022 Q1	$303K	Buy	1,872 +260	+16%	+$37.8K	0.25%	31
2021 Q4	$218K	Buy	+1,612	New	+$190K	0.17%	40

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Northern Capital Management (Washington)'s ABBV Position: Q2 2026 in Review

Northern Capital Management (Washington) held its AbbVie (ABBV) position steady in Q2 2026 at 1,673 shares worth $421K. The position accounts for 0.18% of the portfolio, ranked #33.

Northern Capital Management (Washington) first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Northern Capital Management (Washington) held 1,673 shares of AbbVie worth $421K as of Q2 2026.
Northern Capital Management (Washington) left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.18% of Northern Capital Management (Washington)'s portfolio in Q2 2026, its #33 holding.
Northern Capital Management (Washington) first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Northern Capital Management (Washington)'s 13F filing for Q2 2026, filed 21 Jul 2026.